Глобальный рынок технологий трансфекции – тенденции отрасли и прогноз до 2030 года

Анализ и размер рынка технологий трансфекции

Рынок технологий трансфекции будет быстро расширяться из-за роста заболеваемости раком и увеличения исследований и разработок в области клеточной терапии. По мере того, как растет распространенность рака и растет число людей с ожирением, растет и спрос на трансфекцию. Этот фактор стимулирует рынок технологий трансфекции. Кроме того, инициативы, предпринимаемые различными государственными организациями, усиливают рост рынка.

Компания Data Bridge Market Research анализирует, что рынок технологий трансфекции, который в 2022 году составил 1073,22 млн долларов США, как ожидается, достигнет 2001,22 млн долларов США к 2030 году при среднегодовом темпе роста 8,1% в прогнозируемый период с 2023 по 2030 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные компанией Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативно-правовую базу.

Масштаб и сегментация рынка технологий трансфекции  

Определение рынка

Технология трансфекции вводит нуклеиновые кислоты в клетки, такие как дезоксирибонуклеиновая кислота (ДНК), рибонуклеиновая кислота (РНК) и олигонуклеотиды. Она вводится с помощью различных физических, химических и биологических методов, которые могут помочь в изменении определенных свойств клеток. Котрансфекция, электропорация, катионная липидная трансфекция и трансфекция in vivo — все эти методы используются. Этот метод обычно используется в геномных исследованиях, таких как экспрессия генов, скрининг, РНК-интерференция и исследования Vivo, а также биопродукция вирусов и белков.

Динамика мирового рынка технологий трансфекции

Драйверы

• Внедрение новых продуктов

Котрансфекция — это введение более одного типа нуклеиновой кислоты в эукариотическую клетку. Несколько плазмидных ДНК, siRNA и плазмидной ДНК, а также несколько miRNA в одну и ту же клетку являются примерами комбинаций. Котрансфекция множественной плазмидной ДНК обычно направлена ​​на введение более одного типа чужеродного гена в клетки-хозяева. Одним из ее применений является создание синтетических вирусных или гибридных векторов, состоящих из нескольких компонентов плазмидной ДНК. Примером является создание лентивируса из нескольких плазмидных векторов, таких как векторы переноса, оболочки и упаковки в клеточной линии HEK293. Это некоторые из примеров, которые стимулируют рост рынка.

• Повышение эффективности трансфекции

Эффективность трансфекции можно определить путем котрансфекции малой РНК и плазмидной ДНК. Это возможно путем вставки плазмиды, содержащей ген-репортер люциферазы, 3′ UTR которой может распознаваться определенной малой РНК, такой как miRNA, что позволяет малой РНК связываться и ингибировать экспрессию люциферазы. С другой стороны, котрансфекция малой РНК и плазмидной ДНК требуется в исследованиях РНК-интерференции (RNAi) для определения регуляторных эффектов определенной малой РНК, такой как siRNA, на экспрессию определенного гена в клетке-хозяине.

Opportunities

• Technological advancements

Co-transfection may also involve other small molecules, such as miRNAs, which can be used to study the effects of small RNAs on targeted host cells. For instance, if the introduction of a miRNA mimic can affect the expression of a specific downstream gene in a specific cell type, the simultaneous transfection of its inhibitor sequence into the same cell is expected to reduce the post-transcriptional regulatory effect exerted by the miRNA mimics sequence alone.

Restraints/Challenges

• High cost

The cost of transfection technology instruments and home brew reagents are the major factors acting as restraints. They will further challenge the growth of the transfection technologies market during the forecast period.

This transfection technologies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transfection technologies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Transfection Technologies Market Scope

The transfection technologies market is segmented on the basis of transfection method, technology, end-user, and applications. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Virus Production
• Protein Production
• Gene Silencing
• Stem Cell Reprogramming and Differentiation
• Stable Cell Line Generation
• Therapeutic Delivery
• Bio-Medical Research
• Protein Production
• Others

Transfection Method

• Lipofection
• Eletroporation
• Nucleofection
• Cotransfection
• Cationic Lipid Transfection
• In-Vivo Transfection
• Others

Technology

• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection

End-User

• Pharmaceutical and biotechnology companies
• Contract research organizations
• Academic and research institutes

Transfection Technologies Market Regional Analysis/Insights

The transfection technologies market is analyzed and market size insights and trends are provided by country, transfection method, technology, end-user and applications as referenced above.

The countries covered in the transfection technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transfection technologies market because of an increase in the number of cases of infectious diseases requiring antibiotics and an increase in the use of cell-based products requiring transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to increase in the occurrences of cancer diseases in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The transfection technologies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transfection technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transfection technologies market. The data is available for historic period 2011-2021.

Competitive Landscape and Transfection Technologies Market Share Analysis

The transfection technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transfection technologies market.

Some of the major players operating in the transfection technologies market are:

• Lonza (Switzerland)
• Promega Corporation (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Roche Molecular Systems, Inc. (U.S.)
• QIAGEN (Germany)
• Inovio Pharmaceuticals (U.S.)
• Polyplus Transfection (France)
• Mirus Bio LLC (U.S.)
• Takara Bio Inc. (Japan)
• SignaGen Laboratories (U.S.)
• MaxCyte, Inc. (U.S.)
• Genlantis Inc. (U.S.)
• Techulon (U.S.)
• BioAstrum Corporation (U.S.)
• Altogen Biosystems (U.S.)
• OZ Biosciences (France)
• Boca Scientific, Inc. (U.S.)
• Biontex Laboratories GmbH (Germany)

Research Methodology: Global Transfection Technologies Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

SKU-14548